Neurobiol Dis., 2016 · DOI: 10.1016/j.nbd.2016.04.010 · Published: September 1, 2016
This study investigates how a specific protein, the thrombin receptor (PAR1), affects recovery after spinal cord injury (SCI). The researchers found that mice without PAR1 had better locomotor recovery, reduced inflammation, and less scarring (astrogliosis) in the spinal cord after injury. The study suggests that targeting PAR1 could be a new way to help people recover from SCI by reducing inflammation and promoting tissue repair.
PAR1 is identified as a potential therapeutic target for modulating inflammation and astrogliosis to enhance recovery of locomotor function after SCI.
Small molecule inhibitors of PAR1 are available, providing a rationale for determining their efficacy in improving outcomes after neurological injury.
The identification of a feedforward and feedback signaling circuit centered on PAR1 suggests new strategies for modulating the SCI microenvironment.